#transgene $TNG broke MA200#transgene $TNG broke MA200, closed on high volume. Could see a violent move into 1.75 and then above 2.00
Long
Transgene SA
No trades
No trades
Compare with Transgene SA
−0.17 EUR
−37.52 M EUR
137.00 K EUR
53.18 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Alessandro Riva
Website
Headquarters
Strasbourg
Founded
1979
IPO date
Mar 25, 1998
ISIN
FR0005175080
FIGI
BBG01318WWY0
Identifiers
ISIN FR0005175080
Transgene SA is a biotechnology company that focuses on designing and developing targeted immunotherapies for the treatment of cancer. Its products include TG4001, TG4050, TG6002, BT-001 & TG6050. The company was founded in December 1979 and is headquartered in Strasbourg, France.
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of TGNA is 0.71 EUR — it has decreased by −0.28% in the past 24 hours. Watch Transgene SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Transgene SA stocks are traded under the ticker TGNA.
TGNA stock has risen by 1.13% compared to the previous week, the month change is a −19.78% fall, over the last year Transgene SA has showed a −34.79% decrease.
We've gathered analysts' opinions on Transgene SA future price: according to them, TGNA price has a max estimate of 2.75 EUR and a min estimate of 1.10 EUR. Watch TGNA chart and read a more detailed Transgene SA stock forecast: see what analysts think of Transgene SA and suggest that you do with its stocks.
TGNA reached its all-time high on Jan 29, 2010 with the price of 20.92 EUR, and its all-time low was 0.55 EUR and was reached on Apr 8, 2025. View more price dynamics on TGNA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TGNA stock is 0.84% volatile and has beta coefficient of −0.04. Track Transgene SA stock price on the chart and check out the list of the most volatile stocks — is Transgene SA there?
Today Transgene SA has the market capitalization of 196.73 M, it has increased by 0.83% over the last week.
Yes, you can track Transgene SA financials in yearly and quarterly reports right on TradingView.
Transgene SA is going to release the next earnings report on Mar 31, 2027. Keep track of upcoming events with our Earnings Calendar.
TGNA net income for the last half-year is −15.67 M EUR, while the previous report showed −18.23 M EUR of net income which accounts for 0.00% change. Track more Transgene SA financial stats to get the full picture.
No, TGNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 8, 2026, the company has 156 employees. See our rating of the largest employees — is Transgene SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Transgene SA EBITDA is −37.52 M EUR, and current EBITDA margin is −28.96 K%. See more stats in Transgene SA financial statements.
Like other stocks, TGNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Transgene SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Transgene SA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Transgene SA stock shows the sell signal. See more of Transgene SA technicals for a more comprehensive analysis.